Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Development and evaluation of topical formulations for a novel skin whitening agent (AP736) using Hansen solubility parameters and PEG-PCL polymers.

Shin HJ, Beak HS, Il Kim S, Joo YH, Choi J.

Int J Pharm. 2018 Dec 1;552(1-2):251-257. doi: 10.1016/j.ijpharm.2018.09.064. Epub 2018 Sep 27.

PMID:
30268851
2.

AP736 induces miR-125b expression for the efficient whitening and anti-ageing action in human epidermal cells.

Baek HS, Hwang JA, Bae IH, Kim KH, Joo YH, Kim YJ, Shin HJ, Lee JH, Park YH, Kim JW, Lee CS.

Exp Dermatol. 2017 May;26(5):451-454. doi: 10.1111/exd.13239. Epub 2017 Mar 23. No abstract available.

PMID:
27714863
3.

Antimelanogenic activity of a novel adamantyl benzylbenzamide derivative, AP736: a randomized, double-blind, vehicle-controlled comparative clinical trial performed in patients with hyperpigmentation during the summer.

Jeong YS, Kim JH, Choi J, Baek HS, Joo YH, Lee CS, Shin HJ, Park YH, Kim BJ, Shin SS.

Int J Dermatol. 2016 Jun;55(6):e321-6. doi: 10.1111/ijd.13150. Epub 2015 Dec 29.

PMID:
26712041
4.

Different effects of five depigmentary compounds, rhododendrol, raspberry ketone, monobenzone, rucinol and AP736 on melanogenesis and viability of human epidermal melanocytes.

Lee CS, Joo YH, Baek HS, Park M, Kim JH, Shin HJ, Park NH, Lee JH, Park YH, Shin SS, Lee HK.

Exp Dermatol. 2016 Jan;25(1):44-9. doi: 10.1111/exd.12871. Epub 2015 Nov 23.

PMID:
26440747
5.

A novel adamantyl benzylbenzamide derivative, AP736, inhibits melanogenesis in B16F10 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation.

Shin HJ, Oh CT, Kwon TR, Beak HS, Joo YH, Kim JH, Lee CS, Lee JH, Kim BJ, Shin SS, Park ES.

Int J Mol Med. 2015 Nov;36(5):1353-60. doi: 10.3892/ijmm.2015.2348. Epub 2015 Sep 17.

PMID:
26398893
6.

NF-κB/AP-1-targeted inhibition of macrophage-mediated inflammatory responses by depigmenting compound AP736 derived from natural 1,3-diphenylpropane skeleton.

Ha VT, Beak HS, Kim E, Baek KS, Hossen MJ, Yang WS, Kim Y, Kim JH, Yang S, Kim JH, Joo YH, Lee CS, Choi J, Shin HJ, Hong S, Shin SS, Cho JY.

Mediators Inflamm. 2014;2014:354843. doi: 10.1155/2014/354843. Epub 2014 Oct 19.

7.

Novel inhibitory effect of N-(2-hydroxycyclohexyl)valiolamine on melanin production in a human skin model.

Bin BH, Joo YH, Lee AY, Shin SS, Cho EG, Lee TR.

Int J Mol Sci. 2014 Jul 9;15(7):12188-95. doi: 10.3390/ijms150712188.

8.

Synthesis and structure-activity relationship of cyclopentenone oximes as novel inhibitors of the production of tumor necrosis factor-α.

Kim Y, Hong YD, Joo YH, Woo BY, Kim SY, Koh HJ, Park M, Byoun KH, Shin SS.

Bioorg Med Chem Lett. 2014 Jul 1;24(13):2807-10. doi: 10.1016/j.bmcl.2014.04.115. Epub 2014 May 9.

PMID:
24852119
9.

3D-QSAR study of adamantyl N-benzylbenzamides as melanogenesis inhibitors.

Hong YD, Baek HS, Cho H, Ahn SM, Rho HS, Park YH, Joo YH, Shin SS.

Bioorg Med Chem Lett. 2014 Jan 15;24(2):667-73. doi: 10.1016/j.bmcl.2013.11.056. Epub 2013 Dec 7.

PMID:
24360555
10.
11.

Depigmenting activities of kojic acid derivatives without tyrosinase inhibitory activities.

Cho JC, Rho HS, Joo YH, Lee CS, Lee J, Ahn SM, Kim JE, Shin SS, Park YH, Suh KD, Park SN.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4159-62. doi: 10.1016/j.bmcl.2012.04.046. Epub 2012 Apr 16.

PMID:
22579419
12.

Adamantyl N-benzylbenzamide: new series of depigmentation agents with tyrosinase inhibitory activity.

Baek HS, Hong YD, Lee CS, Rho HS, Shin SS, Park YH, Joo YH.

Bioorg Med Chem Lett. 2012 Mar 1;22(5):2110-3. doi: 10.1016/j.bmcl.2011.12.144. Epub 2012 Jan 11.

PMID:
22300660
13.

Inhibitory activity of novel kojic acid derivative containing trolox moiety on melanogenesis.

Ahn SM, Rho HS, Baek HS, Joo YH, Hong YD, Shin SS, Park YH, Park SN.

Bioorg Med Chem Lett. 2011 Dec 15;21(24):7466-9. doi: 10.1016/j.bmcl.2011.09.122. Epub 2011 Oct 17.

PMID:
22071299
14.

Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents.

Suh YG, Lee YS, Min KH, Park OH, Kim JK, Seung HS, Seo SY, Lee BY, Nam YH, Lee KO, Kim HD, Park HG, Lee J, Oh U, Lim JO, Kang SU, Kil MJ, Koo JY, Shin SS, Joo YH, Kim JK, Jeong YS, Kim SY, Park YH.

J Med Chem. 2005 Sep 8;48(18):5823-36.

PMID:
16134949
15.

Biarylcarboxybenzamide derivatives as potent vanilloid receptor (VR1) antagonistic ligands.

Park HG, Choi JY, Kim MH, Choi SH, Park MK, Lee J, Suh YG, Cho H, Oh U, Kim HD, Joo YH, Shin SS, Kim JK, Jeong YS, Koh HJ, Park YH, Jew SS.

Bioorg Med Chem Lett. 2005 Feb 1;15(3):631-4. Erratum in: Bioorg Med Chem Lett. 2005 Apr 1;15(7):1955.

PMID:
15664827
16.

2,3-diarylpyran-4-ones: a new series of selective cyclooxygenase-2 inhibitors.

Hyup Joo Y, Kwan Kim J, Kang SH, Noh MS, Ha JY, Kyu Choi J, Lim KM, Chung S.

Bioorg Med Chem Lett. 2004 May 3;14(9):2195-8.

PMID:
15081007
17.

Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists.

Ryu CH, Jang MJ, Jung JW, Park JH, Choi HY, Suh YG, Oh U, Park HG, Lee J, Koh HJ, Mo JH, Joo YH, Park YH, Kim HD.

Bioorg Med Chem Lett. 2004 Apr 5;14(7):1751-5.

PMID:
15026064
18.

N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.

Park HG, Choi JY, Choi SH, Park MK, Lee J, Suh YG, Cho H, Oh U, Kim HD, Joo YH, Kim SY, Park YH, Jeong YS, Choi JK, Kim JK, Jew SS.

Bioorg Med Chem Lett. 2004 Apr 5;14(7):1693-6.

PMID:
15026052
19.

Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects.

Suh YG, Lee YS, Min KH, Park OH, Seung HS, Kim HD, Park HG, Choi J, Lee J, Kang SW, Oh UT, Koo JY, Joo YH, Kim SY, Kim JK, Park YH.

Bioorg Med Chem Lett. 2003 Dec 15;13(24):4389-93.

PMID:
14643332
20.

A facile one-pot synthesis of 4,5-diaryl-2,2-dimethyl-3(2H)-furanones.

Lee KW, Choi YH, Joo YH, Kim JK, Shin SS, Byun YJ, Kim Y, Chung S.

Bioorg Med Chem. 2002 Apr;10(4):1137-42.

PMID:
11836125

Supplemental Content

Loading ...
Support Center